Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Transfus Apher Sci ; 54(1): 2-15, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26776481

ABSTRACT

Apheresis with different procedures and devices are used for a variety of indications that may have different adverse events (AEs). The aim of this study was to clarify the extent and possible reasons of various side effects based on data from a multinational registry. The WAA-apheresis registry data focus on adverse events in a total of 50846 procedures in 7142 patients (42% women). AEs were graded as mild, moderate (need for medication), severe (interruption due to the AE) or death (due to AE). More AEs occurred during the first procedures versus subsequent (8.4 and 5.5%, respectively). AEs were mild in 2.4% (due to access 54%, device 7%, hypotension 15%, tingling 8%), moderate in 3% (tingling 58%, urticaria 15%, hypotension 10%, nausea 3%), and severe in 0.4% of procedures (syncope/hypotension 32%, urticaria 17%, chills/fever 8%, arrhythmia/asystole 4.5%, nausea/vomiting 4%). Hypotension was most common if albumin was used as the replacement fluid, and urticaria when plasma was used. Arrhythmia occurred to similar extents when using plasma or albumin as replacement. In 64% of procedures with bronchospasm, plasma was part of the replacement fluid used. Severe AEs are rare. Although most reactions are mild and moderate, several side effects may be critical for the patient. We present side effects in relation to the procedures and suggest that safety is increased by regular vital sign measurements, cardiac monitoring and by having emergency equipment nearby.


Subject(s)
Blood Component Removal/adverse effects , Registries , Societies, Medical , Adolescent , Adult , Aged , Aged, 80 and over , Calcium/administration & dosage , Child , Child, Preschool , Colloids , Female , Humans , Infant , Infant, Newborn , Injections, Intravenous , Male , Middle Aged , Plasma Exchange , Reference Standards , Time Factors , Tissue Donors , Treatment Outcome , Young Adult
2.
Prenat Diagn ; 25(5): 354-7, 2005 May.
Article in English | MEDLINE | ID: mdl-15906424

ABSTRACT

We report on a fetus with multiple congenital anomalies detected at the prenatal ultrasound examination and a trisomy 6 mosaicism in the amniocytes. The pregnancy was interrupted in the 18th gestational week and the autopsy revealed malformations including cleft right hand, arthrogryposis and hypoplasia of the 4th digit of the left hand, syndactylies and overlapping toes, facial dysmorphism with hypertelorism and low-set ears, ventricular septum defect (VSD), intestinal malrotation and scoliosis. Trisomy 6 mosaicism was detected in cultured amniocytes (13.3%), confirmed in umbilical cord fibroblasts (40%) and by fluorescence in situ hybridization on other fetal tissues. Trisomy 6 mosaicism is a very rare finding with only eight cases previously reported to our best knowledge.


Subject(s)
Chromosomes, Human, Pair 6 , Mosaicism , Prenatal Diagnosis , Trisomy/diagnosis , Abnormalities, Multiple/diagnosis , Abnormalities, Multiple/embryology , Abnormalities, Multiple/genetics , Abnormalities, Multiple/pathology , Adult , Diagnosis, Differential , Female , Genetic Counseling , Humans , Pregnancy , Pregnancy Trimester, Second , Trisomy/genetics , Trisomy/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...